Cigall Kadoch

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s /Allan Reine, M.D., Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Cigall Kadoch

Form 4 holding Director

Foghorn Therapeutics Inc.

Security class
Common Stock
Shares / value
3,329,379
Estimated value
$27,467,377
Report date
31 Aug 2022
Price
$8.25
Ownership
Indirect
Form 4 holding Director

Foghorn Therapeutics Inc.

Security class
Common Stock
Shares / value
295,000
Estimated value
$2,433,750
Report date
31 Aug 2022
Price
$8.25
Ownership
Direct
Form 4 holding Director

Foghorn Therapeutics Inc.

Security class
Stock Options (Right to buy)
Shares / value
12,530
Estimated value
$38,342
Report date
31 Aug 2022
Price
$3.06
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,530

Insider Reports Filed by Cigall Kadoch

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .